StoryCommercial
CVRx Q2 2026 revenue rises 16% to $15.7M but full-year guidance is cut to $58-60M
US revenue grew 21% to $14.8M while Europe fell 31% to $0.9M. CEO Kevin Hykes said the company was not satisfied with its lowered outlook. Humana's Medicare Advantage policy covering Barostim took effect on 1 May.
- US units 466 vs 391 a year earlier; active US centres 258 vs 240
- Gross margin 87%; net loss $14.0M; cash $64.6M
- Q3 revenue guided to $13.5-14.5M